FEB 06, 2018 08:41 AM PST

Two Factors That Cause Bipolar Disorder Intertwine

WRITTEN BY: Kara Marker

Two key factors implicated in the development of bipolar disorder (BD) are connected, researchers involved in a new study argue. Treating one factor could thus simultaneously treat the other, potentially offering a new therapeutic option for the nearly six million Americans living with BD.

Fronto-insular regions of grey matter reduction in bipolar disorder. Credit: Wikimedia user Petergstrom

BD is characterized by clear changes in mood, energy, and activity levels, often going back and forth between manic and depressive episodes. Treatment for BD, which is caused by a combination of genetic and environmental factors, usually includes both psychotherapy and medication, including mood stabilizers, atypical antipsychotics, and antidepressants.

A key factor identified in cases of BD is the activity of immediate early genes (IEGs), which enable a quick response to environmental stimuli, like stress. Individuals with BD tend to have a difficult time dealing with stress and adapting to new situations. IEGs activate other genes, resulting in a state called neuronal plasticity, where brain cells learn to adjust and respond to environmental stimuli.

IEGs also produce Early Growth Response (ERG) proteins, which “translate environmental influence into long-term changes in the brain.” ERG proteins are mass-produced in response to stress and sleep deprivation, as they are necessary for the brain to respond to the never-ending supply of environmental stimuli.

Another factor linked to BD are neurotrophins, like the brain-derived neurotrophic factor (BDNF) found in the brain. Past studies have found reduced levels of BDNF linked to BD.

Previous research from a collaborative group of scientists from Universidade Federal do Rio Grande do Sul in Brazil, University of Arizona College of Medicine in the United States, and McMaster University in Canada found that a type of IEG called EGR3 was repressed in the brains of BD patients. EGR3 is vital for the response to stress and other environmental stimuli. This partially explains why people with BD are susceptible to stress and often respond inadequately to stress.

Now, a new study from the same group published in the journal Frontiers in Behavioral Neuroscience, researchers analyzed the connection between EGR3 and BDNF. They believe that both factors are involved in the flawed response to stress present in BD, which could explain the condition’s “impaired cellular resilience.”

“We believe that the reduced level of BDNF that has been extensively observed in BD patients is caused by the fact that EGR3 is repressed in the brain of BD patients,” explained lead author Fabio Klamt. “The two molecules are interconnected in a regulatory pathway that is disrupted in BD patients.”

Going forward, researchers are considering EGR3 is a potential drug target. Because by increasing EGR3’s expression, BDNF is positively affected too, and the overall response to stress could be greatly improved.

Sources: National Institute of Mental Health, Depression and Bipolar Support Alliance, Publicase Comunicacao Cientifica

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JUN 20, 2018
Genetics & Genomics
JUN 20, 2018
The Cause of a Rare Neurological Disease is Identified
In a recent study, scientists sequenced the genome to find the mutation behind a disorder that causes blindness and paralysis....
JUN 30, 2018
Immunology
JUN 30, 2018
CD4 T Cells Responsible for Inflammatory Bowel Disease
A specific subset of immune cells could be targeted to better treat inflammatory bowel disease (IBD). A new University of Alabama at Birmingham study point...
JUL 03, 2018
Clinical & Molecular DX
JUL 03, 2018
Blood Test Deciphers Your Internal Rhythm
A personalized reading of your circadian rhythm could help scientists prescribe the exact time of day that drug treatments will be the most effective. A ne...
JUL 10, 2018
Cardiology
JUL 10, 2018
Going Digital for Heart Disease Detection
A group based out of Scripps has utilized a new, patient-centric, mobile medical device to help diagnosis Atrial Fibrillation....
NOV 01, 2018
Cannabis Sciences
NOV 01, 2018
Meet Anandamide - The "Bliss" Molecule
Many of us are aware of the relatively new discovery of the endocannabinoid system (ECS). This is the system which is hijacked by the famous phytocannabinoid (i.e. from cannabis) compounds......
NOV 13, 2018
Immunology
NOV 13, 2018
Bacteria Offers Solution to Inflammation
A team of researchers surveys the mutualistic relationship between gut bacteria and host in regards to gut inflammation in zebrafish...
Loading Comments...